JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01036Industry : Pharmaceuticals & DrugsHouse : Private
BSE1780.70-14.3 (-0.8 %)
PREV CLOSE ( ) 1795.00
OPEN PRICE ( ) 1752.05
BID PRICE (QTY) 1777.40 (15)
OFFER PRICE (QTY) 1780.55 (1)
VOLUME 776
TODAY'S LOW / HIGH ( )1752.05 1788.20
52 WK LOW / HIGH ( )914.65 1935
NSE1778.35-19.45 (-1.08 %)
PREV CLOSE( ) 1797.80
OPEN PRICE ( ) 1795.00
BID PRICE (QTY) 1778.35 (4)
OFFER PRICE (QTY) 1779.85 (1)
VOLUME 16022
TODAY'S LOW / HIGH( ) 1770.35 1795.00
52 WK LOW / HIGH ( )875 1940
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax5552.335049.025968.853488.922869.93
Adjustment1957.781022.73-461.7279.55237.20
Changes In working Capital-299.20-3024.24-942.0996.99-514.72
Cash Flow after changes in Working Capital7210.913047.514565.053665.462592.41
Cash Flow from Operating Activities6256.121701.353147.852757.471943.26
Cash Flow from Investing Activities-9617.8823.20-2306.76239.28-276.65
Cash Flow from Financing Activities3565.38-1383.85-874.23-3060.51-1557.38
Net Cash Inflow / Outflow203.62340.69-33.14-63.77109.22
Opening Cash & Cash Equivalents565.44224.74257.52321.42212.43
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations0.290.010.36-0.13-0.23
Closing Cash & Cash Equivalent769.34565.44224.74257.52321.42

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.